Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Stuart Lind

Concepts (240)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thrombin
4
2020
175
1.180
Why?
Thrombocytopenia
2
2021
206
1.040
Why?
Clioquinol
6
2011
7
0.980
Why?
Docosahexaenoic Acids
4
2014
91
0.760
Why?
Sinus Thrombosis, Intracranial
1
2021
24
0.660
Why?
Anticoagulants
4
2018
746
0.620
Why?
Copper
3
2010
122
0.580
Why?
Antithrombins
2
2020
71
0.540
Why?
Infusions, Parenteral
1
2018
47
0.540
Why?
Hematologic Tests
1
2017
22
0.530
Why?
Drug Monitoring
2
2018
399
0.490
Why?
Ionophores
3
2009
24
0.440
Why?
Zinc
5
2009
310
0.420
Why?
Partial Thromboplastin Time
1
2014
53
0.410
Why?
Thromboplastin
3
2014
67
0.410
Why?
Antineoplastic Agents
6
2011
2219
0.410
Why?
Vaccination
1
2021
1449
0.360
Why?
Blood Coagulation
4
2016
267
0.350
Why?
Ceruloplasmin
2
2009
10
0.330
Why?
Vitamin B 12 Deficiency
2
2009
81
0.310
Why?
Glutathione Peroxidase
2
2007
40
0.310
Why?
Superoxide Dismutase
4
2012
307
0.300
Why?
Oxyquinoline
1
2009
3
0.300
Why?
Apoptosis
8
2012
2439
0.300
Why?
Algorithms
1
2017
1849
0.300
Why?
Lead Poisoning
1
2009
18
0.300
Why?
Erythrocyte Membrane
1
2009
55
0.290
Why?
Cell Line, Tumor
16
2015
3545
0.290
Why?
Factor Xa Inhibitors
2
2025
195
0.290
Why?
Lead
1
2009
71
0.280
Why?
Metals
1
2009
137
0.280
Why?
Organometallic Compounds
1
2009
110
0.270
Why?
Pyridines
2
2009
610
0.270
Why?
Pipecolic Acids
2
2020
26
0.260
Why?
Gastrectomy
1
2009
164
0.250
Why?
Hirudins
2
2020
52
0.250
Why?
Lysosomes
3
2015
134
0.240
Why?
Metformin
4
2012
328
0.240
Why?
Heparin
3
2017
247
0.230
Why?
Annexin A5
1
2005
23
0.230
Why?
Peptide Fragments
3
2020
693
0.230
Why?
Coagulants
1
2005
20
0.230
Why?
Neoplasms
6
2011
2954
0.220
Why?
Blood Coagulation Tests
2
2016
72
0.220
Why?
Neurodegenerative Diseases
1
2007
147
0.210
Why?
Proteolysis
3
2015
174
0.210
Why?
Protoporphyrins
2
2015
16
0.210
Why?
Proteasome Inhibitors
3
2015
42
0.210
Why?
Rivaroxaban
2
2025
270
0.210
Why?
Chelating Agents
3
2009
75
0.200
Why?
Lipid Peroxidation
4
2014
168
0.190
Why?
Heme Oxygenase-1
2
2014
76
0.190
Why?
Cell Survival
8
2012
1105
0.190
Why?
Gene Expression Regulation, Neoplastic
4
2014
1432
0.190
Why?
Recombinant Fusion Proteins
1
2005
663
0.180
Why?
Down-Regulation
1
2004
614
0.180
Why?
beta Catenin
2
2015
250
0.180
Why?
Breast Neoplasms
7
2012
2418
0.170
Why?
Ovarian Neoplasms
3
2013
604
0.160
Why?
Humans
33
2025
146342
0.160
Why?
Venous Thromboembolism
1
2025
332
0.160
Why?
Signal Transduction
8
2013
5246
0.150
Why?
Thiones
2
2009
12
0.150
Why?
Thrombin Time
2
2020
13
0.140
Why?
Superoxide Dismutase-1
3
2012
13
0.130
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2012
1998
0.130
Why?
Arginine
2
2020
264
0.130
Why?
Blotting, Western
5
2013
1177
0.130
Why?
Immunoassay
1
2017
108
0.130
Why?
Platelet Activation
1
2017
99
0.120
Why?
Cell Proliferation
4
2012
2502
0.120
Why?
Postoperative Complications
1
2009
3034
0.120
Why?
Catalase
2
2007
133
0.110
Why?
Prostatic Neoplasms
1
2003
972
0.110
Why?
Serotonin
1
2017
297
0.110
Why?
Recombinant Proteins
2
2020
1361
0.110
Why?
Proto-Oncogene Proteins c-akt
2
2008
441
0.110
Why?
Thromboembolism
1
2016
129
0.110
Why?
Sulfonamides
2
2020
594
0.100
Why?
Dabigatran
1
2014
30
0.100
Why?
Fanconi Anemia Complementation Group Proteins
1
2014
7
0.100
Why?
beta-Alanine
1
2014
25
0.100
Why?
Basic-Leucine Zipper Transcription Factors
1
2014
43
0.100
Why?
Hospitalization
2
2025
2475
0.100
Why?
NF-kappa B
2
2008
674
0.100
Why?
Wnt Signaling Pathway
1
2015
211
0.090
Why?
Dose-Response Relationship, Drug
4
2016
2022
0.090
Why?
Drug Screening Assays, Antitumor
3
2011
194
0.090
Why?
Benzimidazoles
1
2014
191
0.090
Why?
PPAR alpha
1
2012
56
0.090
Why?
Caspase 3
3
2012
240
0.090
Why?
Chromans
1
2012
25
0.090
Why?
Wnt Proteins
1
2013
131
0.090
Why?
Receptors, Steroid
1
2012
41
0.090
Why?
Mice, Nude
3
2014
668
0.090
Why?
Curcumin
1
2012
29
0.090
Why?
Nitroquinolines
1
2011
1
0.090
Why?
Receptor, IGF Type 1
1
2011
64
0.080
Why?
Antimetabolites, Antineoplastic
1
2012
108
0.080
Why?
Biomarkers
2
2018
4340
0.080
Why?
Vitamin E
2
2012
123
0.080
Why?
Xenograft Model Antitumor Assays
3
2014
930
0.080
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2012
299
0.080
Why?
Aged, 80 and over
3
2025
8391
0.080
Why?
STAT3 Transcription Factor
1
2012
214
0.080
Why?
Drug Synergism
2
2012
354
0.080
Why?
Acetylcysteine
1
2010
139
0.070
Why?
Proto-Oncogene Proteins c-bcl-2
2
2012
237
0.070
Why?
Edetic Acid
1
2009
47
0.070
Why?
Buffers
1
2009
56
0.070
Why?
Citrates
1
2009
41
0.070
Why?
Cell Cycle
2
2009
595
0.070
Why?
Protease Inhibitors
1
2009
103
0.070
Why?
Ethylenediamines
1
2008
7
0.070
Why?
Hydrogen Peroxide
1
2010
337
0.070
Why?
Triazenes
1
2008
6
0.070
Why?
Sodium Chloride
1
2009
138
0.070
Why?
Caspases
2
2009
233
0.070
Why?
Adult
5
2025
41087
0.070
Why?
Plasma
1
2009
222
0.060
Why?
RNA, Small Interfering
2
2013
633
0.060
Why?
Therapeutic Human Experimentation
1
1987
2
0.060
Why?
Ethics
1
1987
5
0.060
Why?
Ethical Review
1
1987
3
0.060
Why?
Human Experimentation
1
1987
12
0.060
Why?
Economics
1
1987
11
0.060
Why?
Inhibitory Concentration 50
1
2007
90
0.060
Why?
Financial Support
1
1987
19
0.060
Why?
Tumor Cells, Cultured
2
2009
882
0.060
Why?
Poly(ADP-ribose) Polymerases
3
2012
88
0.060
Why?
Vitamin B 12
1
2007
140
0.060
Why?
Factor VIIIa
1
2005
5
0.060
Why?
Transcription Factor RelA
1
2006
93
0.060
Why?
Factor X
1
2005
26
0.060
Why?
Vascular Endothelial Growth Factor A
2
2012
545
0.060
Why?
Heparin, Low-Molecular-Weight
1
2005
37
0.060
Why?
Phosphatidylserines
1
2005
62
0.060
Why?
Cell Growth Processes
1
2005
47
0.060
Why?
Aged
4
2025
26432
0.050
Why?
Oxidative Stress
1
2012
1369
0.050
Why?
Cisplatin
1
2007
347
0.050
Why?
Female
12
2025
79499
0.050
Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2004
12
0.050
Why?
Dietary Supplements
1
2009
587
0.050
Why?
Regression Analysis
1
2007
999
0.050
Why?
Blood Vessels
1
2005
164
0.050
Why?
MicroRNAs
1
2010
699
0.050
Why?
Reactive Oxygen Species
3
2012
610
0.050
Why?
Chromosomes, Human
1
2004
45
0.050
Why?
Leiomyosarcoma
1
2004
30
0.050
Why?
Neovascularization, Pathologic
1
2005
287
0.050
Why?
Middle Aged
5
2025
36619
0.050
Why?
Research
1
1987
421
0.050
Why?
Protein Structure, Tertiary
1
2005
834
0.050
Why?
Chromosome Aberrations
1
2004
167
0.050
Why?
Animals
5
2014
38107
0.050
Why?
Prothrombin
1
2003
25
0.050
Why?
Proteasome Endopeptidase Complex
2
2015
155
0.050
Why?
Cattle
1
2005
940
0.050
Why?
Pilot Projects
1
2007
1888
0.040
Why?
Male
5
2025
73396
0.040
Why?
Biomedical Research
1
1987
729
0.040
Why?
Hemorrhage
1
2005
825
0.040
Why?
Mice
3
2009
18297
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2013
974
0.040
Why?
Microscopy, Fluorescence
2
2013
404
0.040
Why?
Case-Control Studies
1
2007
3647
0.040
Why?
Hypoglycemic Agents
1
2009
1412
0.040
Why?
Phosphorylation
2
2015
1724
0.040
Why?
Amino Acids
1
2003
515
0.040
Why?
Infusions, Intravenous
1
2020
432
0.040
Why?
Interleukin-6
1
2003
784
0.030
Why?
TOR Serine-Threonine Kinases
2
2012
455
0.030
Why?
Calibration
1
2016
154
0.030
Why?
Antioxidant Response Elements
1
2014
7
0.030
Why?
Pyridones
1
2016
210
0.030
Why?
Protein Transport
1
2015
443
0.020
Why?
NF-E2-Related Factor 2
1
2014
96
0.020
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2012
19
0.020
Why?
bcl-Associated Death Protein
1
2012
10
0.020
Why?
Genes, Reporter
1
2013
275
0.020
Why?
Aminosalicylic Acids
1
2012
10
0.020
Why?
Prospective Studies
1
2025
8123
0.020
Why?
Benzenesulfonates
1
2012
23
0.020
Why?
DNA Primers
1
2013
487
0.020
Why?
Pyrazoles
1
2016
517
0.020
Why?
Chromones
1
2011
43
0.020
Why?
HL-60 Cells
1
2011
29
0.020
Why?
Immunoprecipitation
1
2011
150
0.020
Why?
Dasatinib
1
2011
58
0.020
Why?
Apoptosis Regulatory Proteins
1
2012
186
0.020
Why?
Antineoplastic Agents, Phytogenic
1
2012
178
0.020
Why?
Trastuzumab
1
2011
119
0.020
Why?
Thiazoles
1
2011
139
0.020
Why?
Morpholines
1
2011
130
0.020
Why?
Ascorbic Acid
1
2012
183
0.020
Why?
Enzyme Activation
1
2012
759
0.020
Why?
3' Untranslated Regions
1
2010
152
0.020
Why?
Base Sequence
1
2013
2123
0.020
Why?
Microscopy, Confocal
1
2010
322
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2011
384
0.020
Why?
Ammonium Chloride
1
2009
4
0.020
Why?
Promoter Regions, Genetic
1
2014
1242
0.020
Why?
Cathepsin D
1
2009
22
0.020
Why?
Neoplasm Invasiveness
1
2010
504
0.020
Why?
Intracellular Membranes
1
2009
76
0.020
Why?
Cell Membrane Permeability
1
2009
88
0.020
Why?
Antioxidants
1
2012
544
0.020
Why?
AMP-Activated Protein Kinases
1
2009
193
0.020
Why?
Young Adult
1
2025
14330
0.020
Why?
Pyrimidines
1
2011
532
0.020
Why?
Biological Transport
1
2009
424
0.020
Why?
Ethics Committees, Clinical
1
1987
4
0.020
Why?
Ethics Committees
1
1987
4
0.020
Why?
Fees and Charges
1
1987
12
0.020
Why?
Research Subjects
1
1987
42
0.020
Why?
Ethics Committees, Research
1
1987
41
0.020
Why?
Academies and Institutes
1
1987
61
0.020
Why?
Organizational Policy
1
1987
76
0.020
Why?
Receptors, Estrogen
1
2009
406
0.010
Why?
Endothelial Cells
1
2012
876
0.010
Why?
Drug Resistance, Neoplasm
1
2011
893
0.010
Why?
Patient Care
1
1987
120
0.010
Why?
Informed Consent
1
1987
195
0.010
Why?
Patients
1
1987
183
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2011
992
0.010
Why?
Pharmaceutical Preparations
1
1987
172
0.010
Why?
Adolescent
1
2025
22557
0.010
Why?
Research Personnel
1
1987
190
0.010
Why?
Cell Line
1
2010
2814
0.010
Why?
Treatment Outcome
1
2020
11821
0.010
Why?
Universities
1
1987
451
0.010
Why?
Insurance, Health
1
1987
318
0.010
Why?
Data Collection
1
1987
650
0.010
Why?
Nucleic Acid Hybridization
1
2004
175
0.010
Why?
Hospitals
1
1987
738
0.010
Why?
Mitochondria
1
2009
997
0.010
Why?
Mutation
1
2012
4093
0.010
Why?
Delivery of Health Care
1
1987
947
0.010
Why?
United States
1
1987
16136
0.000
Why?
Lind's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)